Comparison of Efficacy of Pharmacologic Treatments in Pregnancy- and Lactation-Associated Osteoporosis

1.

Nordin BE, Roper A. Post-pregnancy osteoporosis; a syndrome? Lancet. 1955;268(6861):431–4.

Article  CAS  PubMed  Google Scholar 

2.

Dunne F, Walters B, Marshall T, Heath DA. Pregnancy associated osteoporosis. Clin Endocrinol. 1993;39(4):487–90.

Article  CAS  Google Scholar 

3.

Phillips AJ, Ostlere SJ, Smith R. Pregnancy-associated osteoporosis: does the skeleton recover? Osteoporos Int. 2000;11(5):449–54. https://doi.org/10.1007/s001980070113.

Article  CAS  PubMed  Google Scholar 

4.

Hong N, Kim JE, Lee SJ, Kim SH, Rhee Y. Changes in bone mineral density and bone turnover markers during treatment with teriparatide in pregnancy- and lactation-associated osteoporosis. Clin Endocrinol. 2018;88(5):652–8. https://doi.org/10.1111/cen.13557.

Article  CAS  Google Scholar 

5.

Kyvernitakis I, Reuter TC, Hellmeyer L, Hars O, Hadji P. Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up. Osteoporos Int. 2018;29(1):135–42. https://doi.org/10.1007/s00198-017-4239-1.

Article  CAS  PubMed  Google Scholar 

6.

Li LJ, Zhang J, Gao P, Lv F, Song YW, Chang XY, et al. Clinical characteristics and bisphosphonates treatment of rare pregnancy- and lactation-associated osteoporosis. Clin Rheumatol. 2018;37(11):3141–50. https://doi.org/10.1007/s10067-018-4185-0.

Article  PubMed  Google Scholar 

7.

Laroche M, Talibart M, Cormier C, Roux C, Guggenbuhl P, Degboe Y. Pregnancy-related fractures: a retrospective study of a French cohort of 52 patients and review of the literature. Osteoporos Int. 2017;28(11):3135–42. https://doi.org/10.1007/s00198-017-4165-2.

Article  CAS  PubMed  Google Scholar 

8.

Hadji P, Boekhoff J, Hahn M, Hellmeyer L, Hars O, Kyvernitakis I. Pregnancy-associated osteoporosis: a case-control study. Osteoporos Int. 2017;28(4):1393–9. https://doi.org/10.1007/s00198-016-3897-8.

Article  CAS  PubMed  Google Scholar 

9.

O'Sullivan SM, Grey AB, Singh R, Reid IR. Bisphosphonates in pregnancy and lactation-associated osteoporosis. Osteoporos Int. 2006;17(7):1008–12. https://doi.org/10.1007/s00198-006-0112-3.

Article  CAS  PubMed  Google Scholar 

10.

Lampropoulou-Adamidou K, Trovas G, Stathopoulos IP, Papaioannou NA. Case report: teriparatide treatment in a case of severe pregnancy- and lactation-associated osteoporosis. Hormones (Athens, Greece). 2012;11(4):495–500.

Article  Google Scholar 

11.

Stumpf UC, Kurth AA, Windolf J, Fassbender WJ. Pregnancy-associated osteoporosis: an underestimated and underdiagnosed severe disease. A review of two cases in short- and long-term follow-up. Adv Med Sci. 2007;52:94–7.

CAS  PubMed  Google Scholar 

12.

Jang JY, Lee JG, Jeong IK, Ahn KJ, Chung HY, Yang HI, et al. A case of post-pregnancy osteoporosis combined with ankylosing spondylitis. Rheumatol Int. 2009;29(11):1359–62. https://doi.org/10.1007/s00296-008-0820-4.

Article  PubMed  Google Scholar 

13.

Allali F, Guedirra N, Hajjaj-Hassouni N. A case of post-pregnancy osteoporosis-related spinal fractures in association with ankylosing spondylitis. Clin Rheumatol. 2005;24(4):435–6. https://doi.org/10.1007/s10067-004-1074-5.

Article  PubMed  Google Scholar 

14.

Tran HA, Petrovsky N. Pregnancy-associated osteoporosis with hypercalcaemia. Intern Med J. 2002;32(9–10):481–5.

Article  CAS  PubMed  Google Scholar 

15.

Rillo OL, Di Stefano CA, Bermudez J, Maldonado Cocco JA. Idiopathic osteoporosis during pregnancy. Clin Rheumatol. 1994;13(2):299–304.

Article  CAS  PubMed  Google Scholar 

16.

Grizzo FM, da Silva Martins J, Pinheiro MM, Jorgetti V, Carvalho MD, Pelloso SM. Pregnancy and lactation-associated osteoporosis: bone histomorphometric analysis and response to treatment with zoledronic acid. Calcif Tissue Int. 2015;97(4):421–5. https://doi.org/10.1007/s00223-015-0028-z.

Article  CAS  PubMed  Google Scholar 

17.

Tanriover MD, Oz SG, Sozen T, Kilicarslan A, Guven GS. Pregnancy- and lactation-associated osteoporosis with severe vertebral deformities: can strontium ranelate be a new alternative for the treatment? Spine J. 2009;9(4):e20–4. https://doi.org/10.1016/j.spinee.2008.06.451.

Article  PubMed  Google Scholar 

18.

Smith R, Athanasou NA, Ostlere SJ, Vipond SE. Pregnancy-associated osteoporosis. QJM. 1995;88(12):865–78.

CAS  PubMed  Google Scholar 

19.

Blanch J, Pacifici R, Chines A. Pregnancy-associated osteoporosis: report of two cases with long-term bone density follow-up. Br J Rheumatol. 1994;33(3):269–72.

Article  CAS  PubMed  Google Scholar 

20.

Zhang M, Chen P, Li B, Du J, Pan T, Chen J. Approach to the patient with pregnancy and lactation-associated osteoporosis: a case report and a review of the literature. Medicine (Baltimore). 2017;96(46):e8671. https://doi.org/10.1097/MD.0000000000008671.

Article  Google Scholar 

21.

Honjo S, Mizunuma H. Changes in biochemical parameters of bone turnover and bone mineral density in post-pregnancy osteoporosis. Am J Obstet Gynecol. 2001;185(1):246–7. https://doi.org/10.1067/mob.2001.113910.

Article  CAS  PubMed  Google Scholar 

22.

Anai T, Tomiyasu T, Arima K, Miyakawa I. Pregnancy-associated osteoporosis with elevated levels of circulating parathyroid hormone-related protein: a report of two cases. J Obstet Gynaecol Res. 1999;25(1):63–7.

Article  CAS  PubMed  Google Scholar 

23.

Sarikaya S, Ozdolap S, Acikgoz G, Erdem CZ. Pregnancy-associated osteoporosis with vertebral fractures and scoliosis. Joint Bone Spine. 2004;71(1):84–5. https://doi.org/10.1016/j.jbspin.2003.05.003.

Article  PubMed  Google Scholar 

24.

Vujasinovic-Stupar N, Pejnovic N, Markovic L, Zlatanovic M. Pregnancy-associated spinal osteoporosis treated with bisphosphonates: long-term follow-up of maternal and infants outcome. Rheumatol Int. 2012;32(3):819–23. https://doi.org/10.1007/s00296-011-1816-z.

Article  PubMed  Google Scholar 

25.

Reid IR, Wattie DJ, Evans MC, Budayr AA. Post-pregnancy osteoporosis associated with hypercalcaemia. Clin Endocrinol. 1992;37(3):298–303.

Article  CAS  Google Scholar 

26.

Yeap SS, Fauzi AR, Kong NC, Halim AG, Soehardy Z, Rahimah I, et al. A comparison of calcium, calcitriol, and alendronate in corticosteroid-treated premenopausal patients with systemic lupus erythematosus. J Rheumatol. 2008;35(12):2344–7. https://doi.org/10.3899/jrheum.080634.

Article  CAS  PubMed  Google Scholar 

27.

Fuleihan Gel H, Salamoun M, Mourad YA, Chehal A, Salem Z, Mahfoud Z, et al. Pamidronate in the prevention of chemotherapy-induced bone loss in premenopausal women with breast cancer: a randomized controlled trial. J Clin Endocrinol Metab. 2005;90(6):3209–14. https://doi.org/10.1210/jc.2004-1444.

Article  CAS  Google Scholar 

28.

Minsker DH, Manson JM, Peter CP. Effects of the bisphosphonate, alendronate, on parturition in the rat. Toxicol Appl Pharmacol. 1993;121(2):217–23. https://doi.org/10.1006/taap.1993.1148.

Article  CAS  PubMed  Google Scholar 

29.

Levy S, Fayez I, Taguchi N, Han JY, Aiello J, Matsui D, et al. Pregnancy outcome following in utero exposure to bisphosphonates. Bone. 2009;44(3):428–30. https://doi.org/10.1016/j.bone.2008.11.001.

Article  CAS  PubMed  Google Scholar 

30.

Cohen A. Premenopausal osteoporosis. Endocrinol Metab Clin N Am. 2017;46(1):117–33. https://doi.org/10.1016/j.ecl.2016.09.007.

Article  Google Scholar 

31.

Cohen A, Stein EM, Recker RR, Lappe JM, Dempster DW, Zhou H, et al. Teriparatide for idiopathic osteoporosis in premenopausal women: a pilot study. J Clin Endocrinol Metab. 2013;98(5):1971–81. https://doi.org/10.1210/jc.2013-1172.

Article  CAS  PubMed  PubMed Central  Google Scholar 

32.

Fazeli PK, Wang IS, Miller KK, Herzog DB, Misra M, Lee H, et al. Teriparatide increases bone formation and bone mineral density in adult women with anorexia nervosa. J Clin Endocrinol Metab. 2014;99(4):1322–9. https://doi.org/10.1210/jc.2013-4105.

Article  CAS  PubMed  PubMed Central  Google Scholar 

33.

Choe EY, Song JE, Park KH, Seok H, Lee EJ, Lim SK, et al. Effect of teriparatide on pregnancy and lactation-associated osteoporosis with multiple vertebral fractures. J Bone Miner Metab. 2012;30(5):596–601. https://doi.org/10.1007/s00774-011-0334-0.

Article  CAS  PubMed  Google Scholar 

34.

Polat SB, Evranos B, Aydin C, Cuhaci N, Ersoy R, Cakir B. Effective treatment of severe pregnancy and lactation-related osteoporosis with teriparatide: case report and review of the literature. Gynecol Endocrinol. 2015;31(7):522–5. https://doi.org/10.3109/09513590.2015.1014787.

Article  PubMed  Google Scholar 

35.

Coskun Benlidayi I, Sarpel T, Guzel R. Short-term treatment experience with teriparatide in pregnancy- and lactation-associated osteoporosis. J Obstet Gynaecol. 2014;34(8):736. https://doi.org/10.3109/01443615.2014.920800.

Article  CAS  PubMed  Google Scholar 

36.

Hellmeyer L, Boekhoff J, Hadji P. Treatment with teriparatide in a patient with pregnancy-associated osteoporosis. Gynecol Endocrinol. 2010;26(10):725–8. https://doi.org/10.3109/09513591003649831.

Article  CAS  PubMed  Google Scholar 

37.

Ijuin A, Yoshikata H, Asano R, Tsuburai T, Kikuchi R, Sakakibara H. Teriparatide and denosumab treatment for pregnancy and lactation-associated osteoporosis with multiple vertebral fractures: a case study. Taiwan J Obstet Gynecol. 2017;56(6):863–6. https://doi.org/10.1016/j.tjog.2017.10.028.

Article  PubMed  Google Scholar 

38.

Cohen A, Kamanda-Kosseh M, Recker RR, Lappe JM, Dempster DW, Zhou H, et al. Bone density after teriparatide discontinuation in premenopausal idiopathic osteoporosis. J Clin Endocrinol Metab. 2015;100(11):4208–14. https://doi.org/10.1210/jc.2015-2829.

Article  CAS  PubMed  PubMed Central  Google Scholar 

39.

Tsuchie H, Miyakoshi N, Hongo M, Kasukawa Y, Ishikawa Y, Shimada Y. Amelioration of pregnancy-associated osteoporosis after treatment with vitamin K(2): a report of four patients. Ups J Med Sci. 2012;117(3):336–41. https://doi.org/10.3109/03009734.2012.676573.

Comments (0)

No login
gif